Biomere
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
2 contract research organizations in our directory list at least one of Xenograft Models, Syngeneic Models, PDX Models or In Vivo Imaging, across 2 countries. 1 reports GLP capability and 2 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
Preclinical oncology CROs test whether a cancer therapy shrinks or slows tumors in animal models, at doses that are tolerated and exposures that can be reached in patients. Most work is done in mice, and the choice of model follows from the mechanism of the drug.
Cell-line xenografts grow human tumor lines in immunodeficient mice and are fast, reproducible and inexpensive. Patient-derived xenografts (PDX) keep more of the original tumor biology and are used to test response across many tumors. Syngeneic models implant mouse tumors into mice with intact immune systems, which immuno-oncology agents need, and humanized mice carry human immune cells for agents that act only on human targets. Orthotopic and metastatic models, often tracked with bioluminescence imaging, place tumors in the relevant organ.
Standard endpoints are tumor volume over time, tumor growth inhibition and survival, usually with PK and biomarker sampling to link exposure to effect. Combination studies with standard-of-care agents are common, so ask whether the CRO has dosed those agents before and holds historical control data for them.
Showing 2 CROs. Order rotates daily so no lab is permanently listed first.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
NeuroBridge Biotechnology is a specialized preclinical research organization based in Guangzhou, China, focused on non-human primate (NHP) and pig disease models and exploratory non-GLP translational studies. We support…